Dr. Kashinath G. Yadalam

Psychiatry
1 Lakeshore Dr, Suite 1695, 
Lake Charles, LA 
1 Lakeshore Dr, Suite 1695, 
Lake Charles, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kashinath Yadalam is a Psychiatrist in Lake Charles, Louisiana. His top areas of expertise are Autism Spectrum Disorder, Alzheimer's Disease, and Dementia.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Psychiatry
Licenses
Psychiatry & Neurology in LA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO

Locations

1 Lakeshore Dr, Suite 1695, Lake Charles, LA 70629

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Enrollment Status: Active_not_recruiting
Publish Date: February 13, 2025
Intervention Type: Drug
Study Drug: CM-AT Enzyme
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing Safety, Tolerability and Long-term Efficacy of Bryostatin in the Treatment of Moderately Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing Safety, Tolerability and Long-term Efficacy of Bryostatin in the Treatment of Moderately Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Enrollment Status: Completed
Publish Date: July 31, 2024
Intervention Type: Drug, Other
Study Drug: Bryostatin I
Study Phase: Phase 2
A Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT)
A Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
Enrollment Status: Terminated
Publish Date: September 05, 2021
Intervention Type: Combination product
Study Drug: ABILIFY MYCITE
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Enrollment Status: Completed
Publish Date: October 01, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
8
conditions
Dr. Said H. Cantu
Psychiatry
Expertise in
8
conditions
Dr. Said H. Cantu
Psychiatry
2829 4th Avenue, 
Lake Charles, LA 
 (2.4 miles away)
337-477-7091
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Said Cantu is a Psychiatrist in Lake Charles, Louisiana. Dr. Cantu is highly rated in 8 conditions, according to our data. His top areas of expertise are Major Depression, Dementia, Seasonal Affective Disorder (SAD), and Schizoaffective Disorder. Dr. Cantu is currently accepting new patients.

Expertise in
5
conditions
Dr. Peter M. Mahony
Psychiatry
Expertise in
5
conditions
Dr. Peter M. Mahony
Psychiatry
333 Dr Michael Debakey Dr, Ste. 220, 
Lake Charles, LA 
 (1.0 miles away)
337-478-9331
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Peter Mahony is a Psychiatrist in Lake Charles, Louisiana. Dr. Mahony is highly rated in 5 conditions, according to our data. His top areas of expertise are Schizophrenia, Schizoaffective Disorder, Bipolar Disorder (BPD), and Major Depression. Dr. Mahony is currently accepting new patients.

Expertise in
5
conditions
Dr. Michael J. Prejean
Psychiatry
Expertise in
5
conditions
Dr. Michael J. Prejean
Psychiatry
2021 Crowley Rayne Hwy, 
Rayne, LA 
 (55.5 miles away)
337-788-0091
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Prejean is a Psychiatrist in Rayne, Louisiana. Dr. Prejean is highly rated in 5 conditions, according to our data. His top areas of expertise are Bipolar Disorder (BPD), Schizophrenia, Schizoaffective Disorder, and Seasonal Affective Disorder (SAD). Dr. Prejean is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yadalam's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile